Activity of probiotics, synbiotics and postbiotics

Activity of probiotics, synbiotics and postbiotics. (A). Integrative scheme of probiotic and synbiotic activity. They inhibit the growth of pathogenic microorganisms which cause colitis and colon cancer, regulate intestinal transit, determine the secretion of anti-inflammatory and pro-apoptotic molecules, reduce intestinal inflammation, produce short-chain fatty acids with anti-tumor effects and show a synergistic effect with anti-tumor drugs, inhibit the secretion of pro-tumor molecules (TNF alpha, IFN gamma, IL1beta, IL6, IL8, INOS, COX2, BCL2, BCLXL), contribute to the multiplication of beneficial microorganisms, which improve the metabolism of obese people and those with type 2 diabetes, and contribute to restoring the barrier function of the intestine by restoring tight junctions. (B). Activity of postbiotic products. The effects of relieving symptoms of irritable bowel syndrome, improving intestinal function and regulating the metabolism of obese and overweight people, are present at a systemic level, the fourth, relating to the reduction of inflammation, is produced at a local level and the others are observed in vitro, on different cell lines. Unless one postbiotic that induces activation of the Wnt/beta-catenin signaling pathway (this is a signaling pathway with a dual role and which can inhibit tumor development), all other arrows indicate tumor suppressive activity, either through apoptosis, cytotoxicity or both effects. Each cell type category is marked by a specific color: with purple, cervical cancer cell line HeLa; with pink-brown, colorectal cancer cell lines HCT-116, Caco-2, HCT-8, HT-29, DLD-1 and WiDr; with magenta, gastric cancer cell line HGC-27; with red, breast cancer cell lines MCF-7, ZR-75-1 and MDA-MB-23; with blue, long carcinoma cell lines A549 and CaSki; and with orange, skin cancer cell line A375
Activity of probiotics, synbiotics and postbiotics

Publication

Microbiome and cancer: from mechanistic implications in disease progression and treatment to development of novel antitumoral strategies (2024) Marian Constantin, et al. Front Immunol. 2024;15(NA). Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates IL10 IL10 ncbigene_symbol IL10 3586
Homo sapiens Primates IL4,IL10 IL4 ncbigene_symbol IL4 3565
Homo sapiens Primates TP53,P21,BAX TP53 ncbigene_symbol TP53 7157
Homo sapiens Primates TP53,P21,BAX BAX ncbigene_symbol BAX 581
Homo sapiens Primates TP53,P21,BAX P21 ncbigene_synonym CDKN1A 1026
Homo sapiens Primates TP53,P21,BAX P21 ncbigene_synonym TCEAL1 9338
Homo sapiens Primates TP53,P21,BAX P21 ncbigene_synonym NSG1 27065
Homo sapiens Primates TP53,P21,BAX P21 ncbigene_synonym H3P16 644914
Homo sapiens Primates IFNG, IFNG ncbigene_symbol IFNG 3458
Homo sapiens Primates TNFA, TNFA ncbigene_synonym TNF 7124
Homo sapiens Primates IL6, IL6 ncbigene_symbol IL6 3569
Homo sapiens Primates TNFA,IFNG,ILIB,IL6,IL8 IL8 ncbigene_synonym CXCL8 3576
Homo sapiens Primates BCL2, BCL2 ncbigene_symbol BCL2 596
Homo sapiens Primates INOS,COX2,BCL2,BCLXL COX2 ncbigene_symbol COX2 4513
Homo sapiens Primates INOS,COX2,BCL2,BCLXL COX2 ncbigene_synonym PTGS2 5743
Homo sapiens Primates INOS,COX2,BCL2,BCLXL COX2 ncbigene_synonym MTCO2P12 107075310
Homo sapiens Primates INOS,COX2,BCL2,BCLXL INOS ncbigene_synonym NOS2 4843
Homo sapiens Primates INOS,COX2,BCL2,BCLXL INOS ncbigene_synonym ISYNA1 51477
Homo sapiens Primates GG GG famplex_relations GNG10 2790
Homo sapiens Primates GG GG famplex_relations GNG11 2791
Homo sapiens Primates GG GG famplex_relations GNG12 55970
Homo sapiens Primates GG GG famplex_relations GNG13 51764
Homo sapiens Primates GG GG famplex_relations GNG2 54331
Homo sapiens Primates GG GG famplex_relations GNG3 2785
Homo sapiens Primates GG GG famplex_relations GNG4 2786
Homo sapiens Primates GG GG famplex_relations GNG5 2787
Homo sapiens Primates GG GG famplex_relations GNG7 2788
Homo sapiens Primates GG GG famplex_relations GNG8 94235
Homo sapiens Primates GG GG famplex_relations GNGT1 2792
Homo sapiens Primates GG GG famplex_relations GNGT2 2793
Homo sapiens Primates WNT WNT famplex_relations WNT1 7471
Homo sapiens Primates WNT WNT famplex_relations WNT2 7472
Homo sapiens Primates WNT WNT famplex_relations WNT2B 7482
Homo sapiens Primates WNT WNT famplex_relations WNT3 7473
Homo sapiens Primates WNT WNT famplex_relations WNT3A 89780
Homo sapiens Primates WNT WNT famplex_relations WNT4 54361
Homo sapiens Primates WNT WNT famplex_relations WNT6 7475
Homo sapiens Primates WNT WNT famplex_relations WNT7A 7476
Homo sapiens Primates WNT WNT famplex_relations WNT7B 7477
Homo sapiens Primates WNT WNT famplex_relations WNT8A 7478
Homo sapiens Primates WNT WNT famplex_relations WNT8B 7479
Homo sapiens Primates WNT WNT famplex_relations WNT9A 7483
Homo sapiens Primates WNT WNT famplex_relations WNT9B 7484
Homo sapiens Primates WNT WNT famplex_relations WNT10A 80326
Homo sapiens Primates WNT WNT famplex_relations WNT10B 7480
Homo sapiens Primates WNT WNT famplex_relations WNT11 7481
Homo sapiens Primates WNT WNT famplex_relations WNT16 51384
Homo sapiens Primates WNT WNT famplex_relations WNT5A 7474
Homo sapiens Primates WNT WNT famplex_relations WNT5B 81029
Homo sapiens Primates B-CATENIN CTNNB1 ncbigene_symbol CTNNB1 1499
Homo sapiens Primates KUB-3 KUB3 ncbigene_synonym ATP23 91419
Homo sapiens Primates L-14 L14 ncbigene_synonym RPL14 9045
Homo sapiens Primates L-14 L14 ncbigene_synonym IGKV1D-17 28900

Chemical mentions

Word Match MeSH Name ChEBI
FATTY ACIDS fatty acids fatty acids chebi:35366
DRUGS drugs chebi:23888

Disease mentions

Word Match MeSH Name DOID
CANCER cancer cancer DOID:162
COLITIS colitis colitis DOID:0060180
OBESITY obesity obesity DOID:9970
SYNDROME syndrome syndrome DOID:225
COLON CANCER colon cancer colon cancer DOID:219